Medifast (NYSE:MED) reported quarterly earnings results on February 17, 2026 that exceeded analyst expectations.
The Consumer Cyclical company reported earnings per share of $-0.55, beating the consensus estimate of $-0.80 by $0.25 per share. Revenue came in at $75.1M, beating the estimate of $71.2M.
Medifast's stock moved following the earnings release. The stock currently trades at $10.26 with a market capitalization of $130.0M.


